German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Reversible MAO-A inhibitors (reversible MAOIs, antidepressants). |
| Generic Name : | Moclobemide |
| Drug description : | Yellow scored oblong f-c tablets, 300 mg white scored oblong f-c tablets. Both marked ROCHE and tablet strength. |
| Presentation : | Tablets, moclobemide 150 mg , 300mg . |
| Indications : | Major depression. Social phobia. |
| Adult Dosage : | Depression, initially 300 mg daily in divided doses, after meals; maximum 600 mg daily. Social phobia, 300 mg daily for three days, then 600 mg daily in 2 divided doses for 8 - 12 weeks. Then assess. |
| Child Dosage : | Not recommended. |
| Contra Indications : | Acute confusional states, phaeochromocytoma. |
| Special Precautions : | Severe hepatic impairment, thyrotoxicosis. Patients with excitation or agitiation as predominant feature or schizophrenia. Pregnancy, lactation. Avoid excessive amounts of tyramine rich food. |
| Interactions : | Pethidine, selegiline, 5-HT reuptake inhibitors, tricyclic and tetracyclic antidepressants, trazodone, tyramine, cimetidine, morphine, fentanyl, ephedrine, pseudoephedrine, phenylpropanolamine, dextromethorphan. |
| Adverse Reactions : | Sleep disturbances, agitation, restlessness, irritability, dizziness, headache, paraesthesia, dry mouth, visual disturbances, nausea, diarrhoea, constipation, vomiting, oedema, states. |
| Manufacturer : | Roche |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org

Medical News Feed



